Marco Zecca Selected Research

beta-Lactamases (beta-Lactamase)

4/2022

Isolation of a Colistin-Susceptible MDR Pantoea calida Harboring the mcr-9 Gene Suggests the Silent Spread of the Resistance Factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Zecca Research Topics

Disease

16	Leukemia 11/2021 - 01/2005
15	Infections 04/2022 - 06/2003
15	Neoplasms (Cancer) 01/2022 - 10/2007
13	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 07/2003
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 03/2009
6	Hematologic Neoplasms (Hematological Malignancy) 11/2021 - 04/2011
6	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 07/2006
6	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 01/2008
6	Juvenile Myelomonocytic Leukemia 01/2021 - 01/2005
6	Bronchiolitis Obliterans Syndrome 01/2018 - 08/2002
5	beta-Thalassemia (Cooley's Anemia) 03/2022 - 04/2006
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 08/2008
4	Hodgkin Disease (Hodgkin's Disease) 03/2022 - 11/2013
4	Fanconi Anemia (Fanconi's Anemia) 01/2021 - 10/2007
4	Bone Marrow Failure Disorders 01/2021 - 09/2007
4	Sickle Cell Anemia (Hemoglobin S Disease) 10/2020 - 06/2015
3	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 10/2021 - 01/2019
3	Thalassemia 01/2019 - 04/2006
3	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 10/2018 - 11/2002
3	Lymphoma (Lymphomas) 01/2016 - 10/2010
2	COVID-19 01/2022 - 01/2021
2	Thrombotic Microangiopathies 01/2022 - 09/2017
2	Lung Diseases (Lung Disease) 01/2022 - 01/2020
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022 - 05/2004
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 01/2019
2	Celiac Disease (Celiac Sprue) 01/2021 - 04/2013
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020 - 11/2013
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2019 - 01/2018
2	Shwachman-Diamond Syndrome 07/2012 - 03/2007
2	Vitiligo 03/2012 - 03/2006
2	Hemorrhage 01/2010 - 01/2007
1	Opportunistic Infections (Opportunistic Infection) 07/2022
1	Respiratory Insufficiency (Respiratory Failure) 07/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Wiskott-Aldrich Syndrome 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2021
1	Premature Birth (Birth, Premature) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Rhabdomyosarcoma 11/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2020
1	Virus Diseases (Viral Diseases) 01/2020

Drug/Important Bio-Agent (IBA)

6	fludarabineIBA 03/2022 - 11/2002
6	Inosine Triphosphate (ITP)IBA 01/2021 - 07/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2007
5	Biological ProductsIBA 01/2021 - 09/2007
5	Rituximab (Mabthera)FDA Link 01/2020 - 01/2003
4	Busulfan (Busulfex)FDA Link 03/2022 - 01/2016
4	treosulfanIBA 03/2022 - 07/2012
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 01/2008
3	CytokinesIBA 03/2021 - 09/2007
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 01/2008
3	HLA Antigens (Human Leukocyte Antigens)IBA 10/2014 - 08/2008
2	Monoclonal AntibodiesIBA 01/2022 - 07/2006
2	InterferonsIBA 09/2020 - 09/2007
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 04/2015
2	AntigensIBA 01/2019 - 10/2010
2	Ciprofloxacin (Cipro)FDA LinkGeneric 07/2017 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 04/2005
2	SteroidsIBA 11/2013 - 09/2013
2	Pharmaceutical PreparationsIBA 10/2012 - 03/2006
2	Antiviral Agents (Antivirals)IBA 10/2012 - 06/2003
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 07/2012 - 01/2005
2	AntibodiesIBA 07/2012 - 07/2009
2	Thrombopoietin (c-mpl Ligand)IBA 06/2011 - 09/2007
2	Imatinib Mesylate (Gleevec)FDA Link 07/2009 - 03/2006
1	carbapenemaseIBA 04/2022
1	beta-Lactamases (beta-Lactamase)IBA 04/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	defibrotideIBA 10/2021
1	Interleukin-2 (IL2)IBA 03/2021
1	MelatoninIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2020
1	Dactinomycin (Actinomycin)FDA LinkGeneric 11/2020
1	Ifosfamide FDA LinkGeneric 11/2020
1	Vincristine (Oncovin)FDA LinkGeneric 11/2020
1	PolymersIBA 07/2020
1	MetalsIBA 07/2020
1	OxidesIBA 07/2020
1	NanogelsIBA 07/2020
1	GelsIBA 07/2020
1	Viral DNAIBA 01/2020

Therapy/Procedure

46	Hematopoietic Stem Cell Transplantation 01/2022 - 08/2002
26	Therapeutics 01/2022 - 06/2003
24	Transplantation 10/2020 - 11/2002
15	Drug Therapy (Chemotherapy) 11/2020 - 01/2003
11	Stem Cell Transplantation 11/2021 - 07/2003
5	Cell Transplantation 01/2022 - 01/2020
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016 - 03/2009
2	Radiotherapy 11/2018 - 01/2005
2	Donor Selection 10/2014 - 08/2008
2	Immunotherapy 03/2014 - 10/2010
2	Photopheresis 06/2010 - 07/2003
1	Length of Stay 07/2022
1	Lung Transplantation 07/2022
1	Salvage Therapy 03/2022